Long-term health after sepsis with immunotherapy treatment
Treatments studied
Part of Infections clinical trials.
This study follows patients who had sepsis and received immunotherapy (a treatment that helps the body fight infection) to see how they do in the long term and whether the treatment improves survival and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had sepsis (a dangerous reaction to an infection)
- You have been part of the TESTS study (a research study on sepsis)
- You have left the hospital after getting better
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called thymalfasin, which may help the immune system recover in adults with sepsis (a severe infection that causes organ damage). It aims to see if this treatment can improve immune function and possibly outcomes.
This trial looks at whether thymosin-alpha 1, an immune-support treatment, can help prevent colon cancer from coming back after surgery. It targets people with high-risk stage II or III colon cancer who have had the tumor removed.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at a type of immune cell called 'memory CD8+ T cells' in patients with sepsis, a life-threatening response to infection. The goal is to see if these cells are linked to how severe the sepsis is and the risk of dying. This may help doctors better predict outcomes for people with sepsis.
This study follows people who survived sepsis to understand their long-term health and daily life. It aims to improve support for survivors.
Hear when a new Long-term Effects of Thymosin Alpha 1 Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.